Previous close | 5.95 |
Open | 5.95 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 17.50 |
Expiry date | 2024-11-15 |
Day's range | 5.95 - 5.95 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Performance Analysis and Future Clinical Prospects
BOULDER, Colo., May 10, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET.
BOULDER, Colo., May 09, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.